Expert consensus on the immunization strategy and practice of human papillomavirus vaccine for female adolescents in the Yangtze River Delta region.
10.3760/cma.j.cn112150-20221110-01093
- Collective Name:Affiliated Association for Standardized Management and Practice of Immunization Program, China Association for Vaccines
- Publication Type:Journal Article
- MeSH:
Female;
Adolescent;
Humans;
Papillomavirus Vaccines;
Papillomavirus Infections/prevention & control*;
Human Papillomavirus Viruses;
Uterine Cervical Neoplasms/prevention & control*;
Consensus;
Vaccination;
Immunization Programs
- From:
Chinese Journal of Preventive Medicine
2023;57(2):135-153
- CountryChina
- Language:Chinese
-
Abstract:
Persistent infection of high-risk human papillomavirus (HPV) is the leading cause of cervical cancer. In order to achieve the goal of cervical cancer elimination, the World Health Organization (WHO) proposed the "90-70-90" goal, one of which is "90% of girls fully vaccinated with HPV vaccine by age 15 years". Based on the epidemiological characteristics of HPV infection and the characteristics of HPV vaccine, it is important to give priority to female adolescents to be vaccinated with HPV vaccine. CAV Affiliated Association for Standardized Management and Practice of Immunization Program organized an expert group to develop an expert consensus on the immunization strategy and practice of human papillomavirus vaccine for female adolescents in the Yangtze River Delta region. This consensus introduces HPV infection and related disease burden, safety, efficacy and effectiveness of HPV vaccination for female adolescents, factors affecting the health benefits of HPV vaccination for female adolescents, current HPV vaccination strategies for female adolescents, the expert advice, common problems and precautions in the Yangtze River Delta region. This consensus is developed to guide HPV vaccination for female adolescents in the Yangtze River Delta region and provide reference for other regions.
